ng-nitroarginine methyl ester has been researched along with Coxsackie Virus Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiraoka, Y; Kishimoto, C; Ochiai, H; Takada, H | 1 |
| Allen, G; Herskowitz, A; Hill, SL; Lafond-Walker, A; Landavere, M; Lowenstein, CJ; Rose, NR; Wu, J | 1 |
| Hiraoka, Y; Kishimoto, C; Kurokawa, M; Nakamura, M; Ochiai, H; Shiraki, K; Takada, H | 1 |
| Hayashi, Y; Hirata, K; Hotta, H; Itoh, H; Kanazawa, K; Kawashima, S; Mikami, S; Yokoyama, M | 1 |
4 other study(ies) available for ng-nitroarginine methyl ester and Coxsackie Virus Infections
| Article | Year |
|---|---|
Oral L-arginine prevents murine coxsackievirus B3 myocarditis.
Topics: Administration, Oral; Animals; Arginine; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Enzyme Inhibitors; Male; Mice; Mice, Inbred C3H; Myocarditis; NG-Nitroarginine Methyl Ester; Severity of Illness Index; Survival Rate | 2002 |
Nitric oxide inhibits viral replication in murine myocarditis.
Topics: Amino Acid Sequence; Animals; Antibodies; Arginine; Cell Line; Cells, Cultured; Coxsackievirus Infections; Enterovirus B, Human; Enzyme Induction; Enzyme Inhibitors; Immunohistochemistry; Isoenzymes; Macrophage Activation; Macrophages; Mice; Mice, Inbred Strains; Molecular Sequence Data; Myocarditis; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptide Fragments; Rabbits; Spleen; Transcription, Genetic; Virus Replication | 1996 |
Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Enzyme Inhibitors; Macrophages; Mice; Myocarditis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Viremia; Virus Replication | 1996 |
Low-dose N omega-nitro-L-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3.
Topics: Animals; Blood Pressure; Coxsackievirus Infections; Dinoprostone; Enterovirus; Enzyme Inhibitors; Heart; Male; Mice; Mice, Inbred C3H; Myocarditis; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Reference Values; Survival Analysis | 1997 |